Literature DB >> 2174794

Serum antibodies to polioviruses in a Tuscan population, Italy.

D Reali1, A Carducci, M A Ruschi.   

Abstract

In order to study the serological status of a population against poliomyelitis, neutralizing antibody for the three types of polioviruses were examined in 742 serum specimens from individuals aged from 1 to 70 years and over were collected during 1985. Sixty-two percent of the sera had antibodies (titre greater than or equal to 1:8) to all three polioviruses, while 5% had no poliovirus antibody at all. However the rates of seropositivity did vary with age: the 10-19 age group had the lowest frequency of antibody (38%) to the three viruses and the difference between the percentage of this group and the previous (1-10 years) and following ones (20-70 years and over) was highly significant. The results of this seroprevalence survey indicate a gap in immunity to poliomyelitis in the population examined.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2174794     DOI: 10.1007/BF00150438

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  10 in total

1.  Prevalence of poliovirus neutralizing antibodies. A seroepidemiologic survey of vaccinated and unvaccinated women of fertile age.

Authors:  M E Moschen; G Farisano; C Bonello; G Benussi; F Barbone; V Gasparini; R Trivello
Journal:  Boll Ist Sieroter Milan       Date:  1987

2.  Seroimmunity to polioviruses in an urban population of Italy.

Authors:  A Volpi; G Ragona; W Biondi; G Rocchi; I Archetti
Journal:  Bull World Health Organ       Date:  1976       Impact factor: 9.408

3.  Persistence of antibodies in a population immunized with oral poliovaccine (OPV).

Authors:  H Srámová; V Teplý; E Svandová
Journal:  J Hyg Epidemiol Microbiol Immunol       Date:  1979

4.  Immune status of the population to poliovirus infection in Singapore.

Authors:  K T Goh; S Yamazaki
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

5.  Prevalence of antibody to poliovirus in England and Wales 1984-6.

Authors:  P M White; J Green
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-01

6.  Poliomyelitis: A gap in immunity?

Authors:  D Reid; E J Bell; N R Grist; T S Wilson
Journal:  Lancet       Date:  1973-10-20       Impact factor: 79.321

7.  Serum antibodies to poliomyelitis in Italy.

Authors:  R Santoro; F Lombardi; F Novello; C Amato; F M Ruggeri; M E Grandolfo; I Annesi; C M Cortellessa; F Timperi; R Inglese
Journal:  Bull World Health Organ       Date:  1984       Impact factor: 9.408

8.  Poliovirus antibody in Northern Greece.

Authors:  V Kyriazopoulou-Dalaina
Journal:  J Hyg (Lond)       Date:  1986-06

9.  Paralytic poliomyelitis in Italy (1981-85).

Authors:  F Novello; F Lombardi; C Amato; R Santoro; L Fiore; M E Grandolfo; P Pasquini
Journal:  Eur J Epidemiol       Date:  1987-03       Impact factor: 8.082

10.  Immunization coverage in Italy.

Authors:  S Salmaso; M A Stazi; S Luzi; D Greco
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

  10 in total
  6 in total

1.  Antipoliomyelitis neutralizing antibodies in maternal and neonatal serum.

Authors:  M L Tanzi; P Colotto; M Vignali; P Affanni; U Bracchi; E Bellelli
Journal:  Eur J Epidemiol       Date:  1997-07       Impact factor: 8.082

Review 2.  Poliomyelitis: present epidemiological situation and vaccination problems.

Authors:  C Mensi; F Pregliasco
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

3.  Seroprevalence of antipolio antibodies among children <15 years of age in border provinces in China.

Authors:  HaiBo Wang; Hui Cui; ZhenGrong Ding; Pian Ba; ShuangLi Zhu; Ning Wen; LiXin Hao; Jing Ning; Jie Zhang; De Yang; WenBo Xu; Yong Zhang; ChunXiang Fan; WenZhou Yu; XiaoFeng Liang; HuiMing Luo
Journal:  Clin Vaccine Immunol       Date:  2013-05-15

4.  Persistence of immunity to poliomyelitis among a southern population that received four doses of OPV 5 to over 15 years before.

Authors:  M Triassi; G Ribera; L Barruffo; S Barbone; E Medda; M E Grandolfo
Journal:  Eur J Epidemiol       Date:  1996-02       Impact factor: 8.082

Review 5.  Is EU/EEA population protected from polio?

Authors:  Dre Nijsten; P Carrillo-Santisteve; A Miglietta; J Ruitenberg; P L Lopalco
Journal:  Hum Vaccin Immunother       Date:  2015-04-21       Impact factor: 3.452

6.  Sero-survey of polio antibodies during wild poliovirus outbreak in southern Xinjiang Uygur Autonomous Region, China.

Authors:  Hai-Bo Wang; Shuang-Li Zhu; Jing-Shan Zheng; Ai-Li Gou; Hui Cui; Yong Zhang; Gui-Jun Ning; Chun-Xiang Fan; Yuan-Sheng Chen; Ke-Li Li; Ping Yuan; Chao Ma; Jing Ma; Hui Zheng; Xin-Chun Fan; Xin-Lan Li; Hai-Shu Tang; Xiao-Lei Li; Fan Zhang; Dong-Mei Yan; Dong-Yan Wang; Zhi-Qiang Cui; Li-Ping Ren; Hui Zhu; Hui-Ling Wang; Xiao-Hong Jiang; Hong-Qiu An; Yang Liu; Jing Li; Wen-Bo Xu; Ning Wen; Ai-Qiang Xu; Hui-Ming Luo
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.